We are monitoring the impact of COVID-19 on Diabetic Retinopathy Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 875
Share on
Share on

Global Diabetic Retinopathy Market Size, Share, Trends and Growth Analysis Report – Segmented By Treatment Type, Indication, End User and Region - Industry Forecast (2020 to 2025)

Pulished: February, 2020
ID: 875
Pages: 178

Diabetic Retinopathy Market Size (2020 to 2025)

As per our report, the size of the global diabetic retinopathy market was valued USD 6.97 billion in 2020 and estimated to reach USD 9.73 billion by 2025, showcasing a CAGR of 6.9% from 2020 to 2025. High target disease dominance, product launches by the leading diabetic retinopathy market players, increasing strategic developments such as partnerships and agreements, and favorable research funding scenarios are the key market growth drivers.

It is a medical complication that affects the retina in the eye in diabetic patients. It impacts the blood vessels in the eye, which may lead to vision loss and blindness. Patients have to undergo an eye examination test like Visual acuity test, Pupil dilation, Ophthalmoscopy or fundus photography, Fundus Fluorescein angiography (FFA), Retinal vessel analysis, or Optical coherence tomography (OCT) to confirm the disease. As per the National Center for Biotechnology Information, the populace affected with Diabetic Retinopathy (DR) were 126 million in 2010, and this value to reach 191 million by the end of 2030, which is to influence the growth of the diabetic retinopathy market in the equal pace.

Some interesting statistics about Diabetic Retinopathy:

  • Diabetic Retinopathy affects over 33% of the diabetes patients and is the principal cause of blindness in the 20-79 aged population with diabetes.
  • India, China, and Bangladesh alone are representing over 40% of global diabetic retinopathy burden.
  • In Africa, two-thirds of people with diabetes remain undiagnosed.
  • About 30% of people with Diabetic Retinopathy present the greatest unmet need.
  • In the United States, Diabetic Retinopathy is the leading cause of new cases of legal blindness among adults aged 20 to 79 years.

MARKET DRIVERS

Rising incidences of diabetes, unable to cope up with the retinal screening of patients with diabetes and growth in the awareness among people over the diagnosis and treatment services in the hospitals, are primarily expanding the global diabetic retinopathy market. Additionally, increasing demand for continuous monitoring of the diseases, rising capital income in both developed and developing countries, and growing elderly people population are further fuelling the market growth. Rising demand for cost-effective and protective treatment procedures and having the least quality of diagnosis are estimated to favor the diabetic retinopathy market growth.

MARKET RESTRAINTS

Less knowledge about the treatment options, shortage of skilled ophthalmologists, and strict government rules are some of the major restraints to the market growth.

REPORT COVERAGE

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Analysed

By Treatment Type, Indication, End User and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Analysed

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa

 

This research report on the Global Diabetic Retinopathy Market has been segmented and sub-segmented based on the treatment type, indication, end-user, and region.

Diabetic Retinopathy Market - By Treatment Type

  • Anti-Vascular Endothelial Growth Factor (VEGF) drug
  • Intraocular Steroid Injection
  • Laser Surgery
  • Vitrectomy     

Based on the treatment type, the Anti-Vascular Endothelial Growth Factor (VEGF) segment is leading with the highest shares of the market, followed by the laser treatment segment. The laser treatment is further divided into focal laser treatment and scatter laser treatment. Focal laser treatment is growing tremendously with the rise in the prevalence of early diagnosis. The availability of skilled physicians in managing health disorders is significantly influencing the growth of the market. Also, increasing support from the government through investments is leveraging the growth of the market.

Diabetic Retinopathy Market - By Indication

  • Non-Proliferative Diabetic Retinopathy (NPDR)
    • Mild
    • Moderate
    • Severe
  • Proliferative Diabetic Retinopathy (PDR) 

Based on indication, the Non-proliferative diabetic retinopathy segment is holding dominant shares of the market. On-going research in the development of innovative procedures for diagnosing various diseases is elevating the growth of the market. Increasing the scale of specialty care centers is impacting positively on the growth of the market.

Diabetic Retinopathy Market - By End-User

  • Hospitals
  • Ophthalmic Clinics
  • Ambulatory Surgical Centers

Based on end-user, the Hospitals and clinics end-user segments are having the highest shares of the market. A rise in the constructional activities of hospitals with the latest equipment is primarily boosting up the growth rate of the market. If the diabetes is untreated properly, it may damage blood vessels in the retina of an eye, and this factor is leveling up the demand of the market. Increasing expenditure on healthcare is magnifying the growth of the diabetic retinopathy market.

Diabetic Retinopathy Market - By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Regionally, North American remains the central revenue-generating region; this is happening due to the high obesity rates in this region. 

Europe has a large population of baby boomers. This factor is helping Europe to stand 2nd position in leading the highest shares in the diabetic retinopathy market.

The Asia-Pacific region to grow at the highest CAGR. The growing population of diabetes and the changing lifestyles of the local people are primary factors boosting the market in the Asia Pacific. 

The profitable growth of the Asia-Pacific diabetic retinopathy market is due to a large number of diabetics in this region. Emerging economies such as Japan and China in the Asia-Pacific region will grow significantly during the forecast period due to rising disposable income, growing elderly population, increased funding for diabetes research, and innovation in diagnostics. The Chinese market to increase at a healthy rate, whereas Japan is the largest market in the Asia-Pacific region due to high medical expenses and increasing disposable income. Besides, increased use of Lucent to drive APAC Diabetic Retinopathy Market growth in the area.

TOP COMPANIES IN THE MARKET

List of key companies leading the global diabetic retinopathy market profiled in this report are Bayer Healthcare, Pfizer, Inc., Hoffmann-La Roche Ltd, Regeneron Pharmaceutical, Inc., Novartis AG, Valeant Pharmaceutical International Inc., Abbott Laboratories Inc., Alimera Science, Inc., and Ampio Pharmaceuticals Inc.       

1. Introduction                                                 

                1.1 Market Definition                                    

                1.2 Study Deliverables                                  

                1.3 Base Currency, Base Year and Forecast Periods                                           

                1.4 General Study Assumptions                                

2. Research Methodology                                                           

                2.1 Introduction                                              

                2.2 Research Phases                                      

                                2.2.1 Secondary Research                            

                                2.2.2 Primary Research                 

                                2.2.3 Econometric Modelling                     

                                2.2.4 Expert Validation                  

                2.3 Analysis Design                                         

                2.4 Study Timeline                                          

3. Overview                                                      

                3.1 Executive Summary                                

                3.2 Key Inferences                                         

                3.3 New Developments                                

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                      

                4.1 Market Drivers                                          

                4.2 Market Restraints                                    

                4.3 Key Challenges                                         

                4.4 Current Opportunities in the Market                               

5. Market Segmentation                                                              

                5.1 By Type of Treatment                                            

                                5.1.1 Anti-Vascular Endothelial Growth Factor (VEGF) drug                          

                                5.1.2 Intraocular Steroid Injection                           

                                5.1.3 Laser Surgery                         

                                5.1.4 Vitrectomy                             

                5.2 By Indication                                              

                                5.2.1 Non-Proliferative Diabetic Retinopathy (NPDR)                      

                                                5.2.1.1 Mild       

                                                5.2.1.2 Moderate            

                                                5.2.1.3 Severe  

                                5.2.2 Proliferative Diabetic Retinopathy (PDR)                    

                5.3 By End Users                                             

                                5.3.1 Hospitals                  

                                5.3.2 Ophthalmic Clinics                               

                                5.3.3 Ambulatory Surgical Centers                           

6. Geographical Analysis                                                              

                6.1 North America                                          

                                6.1.1 Introduction                           

                                6.1.2 United States                         

                                6.1.3 Canada                     

                6.2 Europe                                         

                                6.2.1 Introduction                           

                                6.2.2 U.K                             

                                6.2.3 Spain                         

                                6.2.4 Germany                 

                                6.2.5 Italy                           

                                6.2.6 France                      

                6.3 Asia-Pacific                                 

                                6.3.1 Introduction                           

                                6.3.2 China                         

                                6.3.3 India                          

                                6.3.4 Japan                        

                                6.3.5 South Korea                           

                                6.3.6 Australia                  

                6.4 Latin America                                            

                                6.4.1 Introduction                           

                                6.4.2 Brazil                         

                                6.4.3 Mexico                     

                                6.4.4 Argentina                

                                6.4.5 Rest of Latin America                         

                6.5 Middle East & Africa                               

                                6.5.1 Introduction                           

                                6.5.2 Middle-East                            

                                6.5.3 Africa                        

7. Strategic Analysis                                                       

                7.1 PESTLE analysis                                         

                                7.1.1 Political                     

                                7.1.2 Economic                 

                                7.1.3 Social                         

                                7.1.4 Technological                         

                                7.1.5 Legal                          

                                7.1.6 Environmental                      

                7.2 Porter’s Five analysis                                              

                                7.2.1 Bargaining Power of Suppliers                        

                                7.2.2 Bargaining Power of Consumers                    

                                7.2.3 Threat of New Entrants                     

                                7.2.4 Threat of Substitute Products and Services               

                                7.2.5 Competitive Rivalry within the Industry                      

8. Market Leaders' Analysis                                                        

                8.1 Bayer AG                                     

                                8.1.1 Overview                

                                8.1.2 Product Analysis                   

                                8.1.3 Strategic Evaluation and Operations                            

                                8.1.4 Financial analysis                  

                                8.1.5 Legal issues                            

                                8.1.6 Recent Developments                       

                                8.1.7 SWOT analysis                       

                                8.1.8 Analyst View                          

                8.2 Pfizer Inc.                                    

                8.3 Hoffmann-La Roche ltd                                          

                8.4 Regeneron Pharmaceutical Inc.                                         

                8.5 Novartis AG                                

                8.6 Valeant Pharmaceutical International Inc.                                     

                8.7 Abbott Laboratories Inc.                                       

                8.8 Alimera Science Inc.                                                

                8.9 Ampio Pharmaceuticals Inc.                                

9. Competitive Landscape                                                           

                9.1 Market share analysis                                            

                9.2 Merger and Acquisition Analysis                                        

                9.3 Agreements, collaborations and Joint Ventures                                          

                9.4 New Product Launches                                          

10. Expert Opinions                                                        

                10.1 Market Outlook                                     

                10.2 Investment Opportunities                                 

Appendix                                                           

                a) List of Tables                                

                b) List of Figures                                              

  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Global Diabetic Retinopathy Market, By Region, From 2020 to 2025 (USD Million)
  2. Global Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  3. Global Anti-Vascular Endothelial Growth Factor (VEGF) drug Market, By Region, From 2020 to 2025 (USD Million)
  4. Global Intraocular Steroid Injection Market, By Region, From 2020 to 2025 (USD Million)
  5. Global Laser Surgery Market, By Region, From 2020 to 2025 (USD Million)
  6. Global Vitrectomy Market, By Region, From 2020 to 2025 (USD Million)
  7. Global Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  8. Global Non-Proliferative Diabetic Retinopathy (NPDR) Market, By Region, From 2020 to 2025 (USD Million)
  9. Global Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  10. Global Mild Indication Market, By Region, From 2020 to 2025 (USD Million)
  11. Global Moderate Indication Market, By Region, From 2020 to 2025 (USD Million)
  12. Global Severe Indication Market, By Region, From 2020 to 2025 (USD Million)
  13. Global Proliferative Diabetic Retinopathy (PDR) Market, By Region, From 2020 to 2025 (USD Million)
  14. Global Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  15. Global Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  16. Global Ophthalmic Clinics Market, By Region, From 2020 to 2025 (USD Million)
  17. Global Ambulatory Surgical Centers Market, By Region, From 2020 to 2025 (USD Million)
  18. North America Diabetic Retinopathy Market, By Region, From 2020 to 2025 (USD Million)
  19. North America Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  20. North America Anti-Vascular Endothelial Growth Factor (VEGF) drug Market, By Region, From 2020 to 2025 (USD Million)
  21. North America Intraocular Steroid Injection Market, By Region, From 2020 to 2025 (USD Million)
  22. North America Laser Surgery Market, By Region, From 2020 to 2025 (USD Million)
  23. North America Vitrectomy Market, By Region, From 2020 to 2025 (USD Million)
  24. North America Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  25. North America Non-Proliferative Diabetic Retinopathy (NPDR) Market, By Region, From 2020 to 2025 (USD Million)
  26. North America Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  27. North America Mild Indication Market, By Region, From 2020 to 2025 (USD Million)
  28. North America Moderate Indication Market, By Region, From 2020 to 2025 (USD Million)
  29. North America Severe Indication Market, By Region, From 2020 to 2025 (USD Million)
  30. North America Proliferative Diabetic Retinopathy (PDR) Market, By Region, From 2020 to 2025 (USD Million)
  31. North America Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  32. North America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  33. North America Ophthalmic Clinics Market, By Region, From 2020 to 2025 (USD Million)
  34. North America Ambulatory Surgical Centers Market, By Region, From 2020 to 2025 (USD Million)
  35. United States Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  36. United States Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  37. United States Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  38. United States Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  39. Canada Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  40. Canada Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  41. Canada Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  42. Canada Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  43. Europe Diabetic Retinopathy Market, By Region, From 2020 to 2025 (USD Million)
  44. Europe Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  45. Europe Anti-Vascular Endothelial Growth Factor (VEGF) drug Market, By Region, From 2020 to 2025 (USD Million)
  46. Europe Intraocular Steroid Injection Market, By Region, From 2020 to 2025 (USD Million)
  47. Europe Laser Surgery Market, By Region, From 2020 to 2025 (USD Million)
  48. Europe Vitrectomy Market, By Region, From 2020 to 2025 (USD Million)
  49. Europe Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  50. Europe Non-Proliferative Diabetic Retinopathy (NPDR) Market, By Region, From 2020 to 2025 (USD Million)
  51. Europe Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  52. Europe Mild Indication Market, By Region, From 2020 to 2025 (USD Million)
  53. Europe Moderate Indication Market, By Region, From 2020 to 2025 (USD Million)
  54. Europe Severe Indication Market, By Region, From 2020 to 2025 (USD Million)
  55. Europe Proliferative Diabetic Retinopathy (PDR) Market, By Region, From 2020 to 2025 (USD Million)
  56. Europe Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  57. Europe Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  58. Europe Ophthalmic Clinics Market, By Region, From 2020 to 2025 (USD Million)
  59. Europe Ambulatory Surgical Centers Market, By Region, From 2020 to 2025 (USD Million)
  60. U.K Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  61. U.K Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  62. U.K Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  63. U.K Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  64. Spain Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  65. Spain Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  66. Spain Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  67. Spain Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  68. Germany Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  69. Germany Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  70. Germany Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  71. Germany Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  72. Italy Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  73. Italy Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  74. Italy Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  75. Italy Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  76. France Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  77. France Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  78. France Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  79. France Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  80. Asia-Pacific Diabetic Retinopathy Market, By Region, From 2020 to 2025 (USD Million)
  81. Asia-Pacific Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  82. Asia-Pacific Anti-Vascular Endothelial Growth Factor (VEGF) drug Market, By Region, From 2020 to 2025 (USD Million)
  83. Asia-Pacific Intraocular Steroid Injection Market, By Region, From 2020 to 2025 (USD Million)
  84. Asia-Pacific Laser Surgery Market, By Region, From 2020 to 2025 (USD Million)
  85. Asia-Pacific Vitrectomy Market, By Region, From 2020 to 2025 (USD Million)
  86. Asia-Pacific Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  87. Asia-Pacific Non-Proliferative Diabetic Retinopathy (NPDR) Market, By Region, From 2020 to 2025 (USD Million)
  88. Asia-Pacific Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  89. Asia-Pacific Mild Indication Market, By Region, From 2020 to 2025 (USD Million)
  90. Asia-Pacific Moderate Indication Market, By Region, From 2020 to 2025 (USD Million)
  91. Asia-Pacific Severe Indication Market, By Region, From 2020 to 2025 (USD Million)
  92. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market, By Region, From 2020 to 2025 (USD Million)
  93. Asia-Pacific Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  94. Asia-Pacific Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  95. Asia-Pacific Ophthalmic Clinics Market, By Region, From 2020 to 2025 (USD Million)
  96. Asia-Pacific Ambulatory Surgical Centers Market, By Region, From 2020 to 2025 (USD Million)
  97. China Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  98. China Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  99. China Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  100. China Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  101. India Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  102. India Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  103. India Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  104. India Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  105. Japan Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  106. Japan Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  107. Japan Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  108. Japan Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  109. South Korea Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  110. South Korea Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  111. South Korea Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  112. South Korea Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  113. Australia Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  114. Australia Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  115. Australia Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  116. Australia Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  117. Latin America Diabetic Retinopathy Market, By Region, From 2020 to 2025 (USD Million)
  118. Latin America Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  119. Latin America Anti-Vascular Endothelial Growth Factor (VEGF) drug Market, By Region, From 2020 to 2025 (USD Million)
  120. Latin America Intraocular Steroid Injection Market, By Region, From 2020 to 2025 (USD Million)
  121. Latin America Laser Surgery Market, By Region, From 2020 to 2025 (USD Million)
  122. Latin America Vitrectomy Market, By Region, From 2020 to 2025 (USD Million)
  123. Latin America Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  124. Latin America Non-Proliferative Diabetic Retinopathy (NPDR) Market, By Region, From 2020 to 2025 (USD Million)
  125. Latin America Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  126. Latin America Mild Indication Market, By Region, From 2020 to 2025 (USD Million)
  127. Latin America Moderate Indication Market, By Region, From 2020 to 2025 (USD Million)
  128. Latin America Severe Indication Market, By Region, From 2020 to 2025 (USD Million)
  129. Latin America Proliferative Diabetic Retinopathy (PDR) Market, By Region, From 2020 to 2025 (USD Million)
  130. Latin America Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  131. Latin America Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  132. Latin America Ophthalmic Clinics Market, By Region, From 2020 to 2025 (USD Million)
  133. Latin America Ambulatory Surgical Centers Market, By Region, From 2020 to 2025 (USD Million)
  134. Brazil Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  135. Brazil Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  136. Brazil Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  137. Brazil Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  138. Argentina Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  139. Argentina Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  140. Argentina Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  141. Argentina Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  142. Mexico Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  143. Mexico Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  144. Mexico Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  145. Mexico Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  146. Middle East & Africa Diabetic Retinopathy Market, By Region, From 2020 to 2025 (USD Million)
  147. Middle East & Africa Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  148. Middle East & Africa Anti-Vascular Endothelial Growth Factor (VEGF) drug Market, By Region, From 2020 to 2025 (USD Million)
  149. Middle East & Africa Intraocular Steroid Injection Market, By Region, From 2020 to 2025 (USD Million)
  150. Middle East & Africa Laser Surgery Market, By Region, From 2020 to 2025 (USD Million)
  151. Middle East & Africa Vitrectomy Market, By Region, From 2020 to 2025 (USD Million)
  152. Middle East & Africa Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  153. Middle East & Africa Non-Proliferative Diabetic Retinopathy (NPDR) Market, By Region, From 2020 to 2025 (USD Million)
  154. Middle East & Africa Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  155. Middle East & Africa Mild Indication Market, By Region, From 2020 to 2025 (USD Million)
  156. Middle East & Africa Moderate Indication Market, By Region, From 2020 to 2025 (USD Million)
  157. Middle East & Africa Severe Indication Market, By Region, From 2020 to 2025 (USD Million)
  158. Middle East & Africa Proliferative Diabetic Retinopathy (PDR) Market, By Region, From 2020 to 2025 (USD Million)
  159. Middle East & Africa Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  160. Middle East & Africa Hospitals Market, By Region, From 2020 to 2025 (USD Million)
  161. Middle East & Africa Ophthalmic Clinics Market, By Region, From 2020 to 2025 (USD Million)
  162. Middle East & Africa Ambulatory Surgical Centers Market, By Region, From 2020 to 2025 (USD Million)
  163. Middle East Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  164. Middle East Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  165. Middle East Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  166. Middle East Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)
  167. Africa Diabetic Retinopathy Market, By Treatment Type, From 2020 to 2025 (USD Million)
  168. Africa Diabetic Retinopathy Market, By Indication, From 2020 to 2025 (USD Million)
  169. Africa Diabetic Retinopathy Market, By Non-Proliferative Diabetic Retinopathy (NPDR) Type, From 2020 to 2025 (USD Million)
  170. Africa Diabetic Retinopathy Market, By End Users, From 2020 to 2025 (USD Million)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample